Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.52 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
| ▸ | PLG | P00747 | 1/20 | 0.50 |
| ▸ | ELANE | P08246 | 1/20 | 0.50 |
| ▸ | CTSG | P08311 | 1/20 | 0.50 |
| ▸ | CMA1 | P23946 | 1/20 | 0.50 |
| ▸ | CTRC | Q99895 | 1/20 | 0.50 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.45 |
| ▸ | MC4R | P32245 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | DRD4 | P21917 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.42 |
| ▸ | GSK3A | P49840 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL1046639 | 0.98 | SIGMAR1 (0.50) | SIGMAR1F2PLGELANECTSG | |
| Hydrochloric Acid SCHEMBL9343069 | 0.98 | SIGMAR1 (0.50) | SIGMAR1F2PLGELANECTSG | |
| SCHEMBL3457652 | 0.89 | SIGMAR1 (0.43) | SIGMAR1F2PLGELANECTSG | |
| Phosphoric Acid SCHEMBL28041604 | 0.88 | F2 (0.45) | SIGMAR1F2PLGELANECTSG | |
| Acetic Acid SCHEMBL28332665 | 0.88 | CYP2D6 (0.49) | F2PLGELANECTSGCMA1 | |
| SCHEMBL12220164 | 0.88 | BCHE (0.47) | SIGMAR1F2PLGELANECTSG | |
| SCHEMBL2215754 | 0.88 | LMNA (0.61) | SIGMAR1KDM4EALDH1A1L3MBTL1LMNA | |
| Pyridine SCHEMBL27430865 | 0.88 | CYP19A1 (0.44) | SIGMAR1F2PLGELANECTSG | |
| SCHEMBL27994068 | 0.87 | SIGMAR1 (0.45) | SIGMAR1F2PLGELANECTSG | |
| SCHEMBL5295885 | 0.86 | MEN1 (0.44) | SIGMAR1F2PLGELANECTSG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010842-A | Separation and purification method for cis-1, 3-dibenzylimidazole-2-ketone-4, 5-dicarboxylic acid in crude cyclic acid | 浙江中贤生物科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12270152-B2 | Dissolution of cellulose in ionic liquids | TEXAS TECH UNIVERSITY SYSTEM (US) | 2025-04-08 | — | — | US | claimed |
| US-20240262937-A1 | Preparation of Chitin Nanocrystals and Nanowhiskers from Crustacean Biomass Using Ionic Liquid | TEXAS TECH UNIVERSITY SYSTEM | 2024-08-08 | — | — | US | claimed |
| WO-2023059499-A1 | PREPARATION OF CHITIN NANOCRYSTALS AND NANOWHISKERS FROM CRUSTACEAN BIOMASS USING IONIC LIQUID | TEXAS TECH UNIVERSITY SYSTEM (US) | 2023-04-13 | — | — | WO | claimed |
| US-11377535-B2 | Carbon fiber recovery compositions and methods | THE BOEING COMPANY (US) | 2022-07-05 | — | — | US | claimed |
| CN-111334004-B | High-elasticity polyester chip and preparation method thereof | 扬州君禾薄膜科技有限公司 | 2022-04-26 | — | — | CN | claimed |
| US-20210079593-A1 | Dissolution of Cellulose in Ionic Liquids | TEXAS TECH UNIVERSITY SYSTEM | 2021-03-18 | — | — | US | claimed |
| CN-111730243-A | Water-soluble flux composition for hot air leveling | 东莞市硕美电子材料科技有限公司 | 2020-10-02 | — | — | CN | claimed |
| US-20200207940-A1 | Carbon Fiber Recovery Compositions and Methods | THE BOEING COMPANY | 2020-07-02 | — | — | US | claimed |
| US-10611892-B2 | Carbon fiber recovery compositions and methods | THE BOEING COMPANY (US) | 2020-04-07 | — | — | US | claimed |
| CN-108062998-A | Conductive nano carbon paste composition and preparation method thereof | 深圳市源恒来实业有限公司 | 2018-05-22 | — | — | CN | claimed |
| CN-106117518-A | A kind of imidazoles epoxy resin cure formula | 柳州市强威锻造厂 | 2016-11-16 | — | — | CN | claimed |
| US-9072729-B2 | Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-07-07 | — | — | US | claimed |
| US-20110178040-A1 | METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-07-21 | — | — | US | claimed |
| CN-101983057-A | Methods of treating fibrosis and cancer with imidazole and imidazoline compounds | AGENCY SCIENCE TECH & RES | 2011-03-02 | — | — | CN | claimed |
| US-20110028513-A1 | METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-02-03 | — | — | US | claimed |
| EP-2271338-A1 | METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | Agency for Science, Technology And Research (SG) | 2011-01-12 | — | — | EP | claimed |
| EP-2249832-A1 | METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | Agency for Science, Technology And Research (SG) | 2010-11-17 | — | — | EP | claimed |
| WO-2009123569-A1 | METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-10-08 | — | — | WO | claimed |
| WO-2009096905-A1 | METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-08-06 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028513-A1 | METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | SMN1; SMN2, INA, NLN | SIGMAR1 2605/4885F2 4675/4885PLG 1657/4885 |
| US-20110178040-A1 | METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | MMP1, MYLK, MMP8 | SIGMAR1 2971/4885F2 2523/4885PLG 1680/4885 |
| US-12270152-B2 | Dissolution of cellulose in ionic liquids | CEL, MGAM, SI | SIGMAR1 2187/4885F2 2648/4885PLG 2879/4885 |
| US-20210079593-A1 | Dissolution of Cellulose in Ionic Liquids | CEL, MGAM, SI | SIGMAR1 2187/4885F2 2648/4885PLG 2879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.